Read recommendations for the perioperative management of antirheumatic medication in rheumatic disease patients undergoing total hip or total knee arthroplasty.

19 июн. 2022 г. · For patients with RA, AS, PsA, or JIA undergoing THA or TKA, withholding tofacitinib, baricitinib, and upadacitinib for at least 3 days prior to ... Abstract · INTRODUCTION · METHODS · DISCUSSION

This updated guideline includes recently introduced immunosuppressive medications to help decision-making by clinicians and patients regarding perioperative ...

This study aims to do a review of the perioperative management of the most commonly used drugs in rheumatologic patients.

14 апр. 2022 г. · New ACR/AAHKS recommendations highlight medication dosage and timing for people with rheumatic conditions, such as lupus and inflammatory arthritis, undergoing ...

The guideline addresses the perioperative use of antirheumatic drug therapy including traditional disease-modifying antirheumatic drugs, biologic agents, ...

7,8 This article discusses the specific risks that are increased in these patients by virtue of their underlying inflammatory diseases and medications.

6 апр. 2022 г. · General Recommendations ; Cyclosporine, Twice daily, Anytime ; Tacrolimus, Twice daily (IV and PO), Anytime ; Rituximab, Every 4 to 6 months IV ...

18 авг. 2023 г. · Outline · - Glucocorticoids · - Nonsteroidal antiinflammatory drugs · - Nonbiologic DMARDs · - Biologic DMARDs · - Janus kinase inhibitors · - Other ...

20 июн. 2022 г. · Guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee ...